Literature DB >> 7870986

Physical dependence on nicotine gum: effect of duration of use.

D Hatsukami1, M Huber, A Callies, K Skoog.   

Abstract

This study examined whether longer duration on nicotine gum promoted dependence on nicotine gum. Subjects (N = 128) answering an advertisement for smoking cessation research and wanting to quit smoking cigarettes were randomly assigned to 1- or 3-month duration of nicotine gum use. Assessments were made weekly for smoking status (with biochemical verification) and withdrawal symptoms during and at the end of treatment. Follow-up was conducted at 1, 6 and 12 months to provide exploratory data on treatment outcome. The results showed minimal nicotine gum withdrawal symptoms after gum cessation with virtually no difference in gum withdrawal between the 1- and 3-month groups. Withdrawal symptoms from the nicotine gum included difficulty with concentration, increased variability on a reaction time task, and decreased vigor. The results also showed that continuous use of the gum at 1 year was observed in 1.5% of subjects and estimated to be as high as 14%. Finally, the 3-month group experienced a 2-fold increase in abstinence compared to the 1-month group, although this difference was not statistically significant. We conclude that there is minimal physical dependence on nicotine gum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870986     DOI: 10.1007/bf02253535

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Long-term use of nicotine vs placebo gum.

Authors:  J R Hughes; S W Gust; R Keenan; J W Fenwick; K Skoog; S T Higgins
Journal:  Arch Intern Med       Date:  1991-10

2.  Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking.

Authors:  P Tønnesen; V Fryd; M Hansen; J Helsted; A B Gunnersen; H Forchammer; M Stockner
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

3.  Evaluation of a treatment approach combining nicotine gum with self-guided behavioral treatments for smoking relapse prevention.

Authors:  J D Killen; S P Fortmann; B Newman; A Varady
Journal:  J Consult Clin Psychol       Date:  1990-02

4.  Long-term use of nicotine chewing gum. Occurrence, determinants, and effect on weight gain.

Authors:  P Hajek; P Jackson; M Belcher
Journal:  JAMA       Date:  1988-09-16       Impact factor: 56.272

5.  Weight change following smoking cessation: the role of food intake and exercise.

Authors:  J Rodin
Journal:  Addict Behav       Date:  1987       Impact factor: 3.913

6.  Weight gain after cessation of smoking.

Authors:  J E Lincoln
Journal:  JAMA       Date:  1969-12-01       Impact factor: 56.272

7.  A comparison of psychological and pharmacological treatment in smoking cessation.

Authors:  K O Fagerström
Journal:  J Behav Med       Date:  1982-09

8.  Nicotine gum to help stop smoking.

Authors:  J R Hughes; S A Miller
Journal:  JAMA       Date:  1984 Nov 23-30       Impact factor: 56.272

9.  Nicotine gum and self-help manuals in smoking cessation: an evaluation in a medical context.

Authors:  J M Harackiewicz; L W Blair; C Sansone; J A Epstein; R N Stuchell
Journal:  Addict Behav       Date:  1988       Impact factor: 3.913

Review 10.  Clinical use of nicotine chewing-gum.

Authors:  M A Russell; M Raw; M J Jarvis
Journal:  Br Med J       Date:  1980-06-28
View more
  7 in total

1.  Dependence on tobacco and nicotine products: a case for product-specific assessment.

Authors:  Karl Fagerström; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2012-03-29       Impact factor: 4.244

2.  Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.

Authors:  Michael Kotlyar; Louise A Hertsgaard; Bruce R Lindgren; Joni A Jensen; Steven G Carmella; Irina Stepanov; Sharon E Murphy; Stephen S Hecht; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-10       Impact factor: 4.254

3.  Subjective effects of the nicotine lozenge: assessment of abuse liability.

Authors:  Elisabeth J Houtsmuller; Jack E Henningfield; Maxine L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  2003-03-04       Impact factor: 4.530

Review 4.  The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments.

Authors:  N G Schneider; R E Olmstead; M A Franzon; E Lunell
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 5.  Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?

Authors:  Tammy Harris Sims; Michael C Fiore
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Reduced nicotine content cigarettes and nicotine patch.

Authors:  Dorothy K Hatsukami; Louise A Hertsgaard; Rachel I Vogel; Joni A Jensen; Sharon E Murphy; Stephen S Hecht; Steven G Carmella; Mustafa al'Absi; Anne M Joseph; Sharon S Allen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-19       Impact factor: 4.254

7.  Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.

Authors:  Dorothy K Hatsukami; Michael Kotlyar; Louise A Hertsgaard; Yan Zhang; Steven G Carmella; Joni A Jensen; Sharon S Allen; Peter G Shields; Sharon E Murphy; Irina Stepanov; Stephen S Hecht
Journal:  Addiction       Date:  2010-02       Impact factor: 6.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.